• Latest Posts

Roche dishes out €509M for a Humanized antibody against Rheumatoid Arthritis

Fixing the ‘Galapagos-AbbVie Disaster’ through a Cystic Fibrosis Therapy

Biotech of the week: Enterome, the Leading French Microbiome Start-up

Biotech of the week: Cell2b, the Promising Portuguese Cell Therapy Biotech

Gut bacteria growth time can cause disease?

Arderlyx’s ‘hot potato’: Sanofi changes its mind about €175M pre-clinical research deal


Now it’s Clear, AbbVie Has to Buy Galapagos’ Drug

Ferring bets on bacteriophages to treat inflammatory bowel disease

Green light for one of the largest clinical trials in Immunotherapy

Are AbbVie and J&J already fighting to acquire Galapagos’ pipeline?

Samsung Bioepis Submits a Biosimilar Candidate, to the European Medicines Agency

Celltrion launches world’s first biosimilar monoclonal antibody in 12 new European markets